|
WNK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.112250E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.255240E-01 |
| Normal-vs-Stage2 |
1.769650E-01 |
| Normal-vs-Stage3 |
7.888300E-02 |
| Normal-vs-Stage4 |
3.481200E-01 |
| Stage1-vs-Stage2 |
9.384200E-01 |
| Stage1-vs-Stage3 |
7.060800E-01 |
| Stage1-vs-Stage4 |
6.872600E-01 |
| Stage2-vs-Stage3 |
8.546000E-01 |
| Stage2-vs-Stage4 |
6.989200E-01 |
| Stage3-vs-Stage4 |
5.430800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.343360E-01 |
| Normal-vs-AfricanAmerican |
6.628200E-01 |
| Normal-vs-Asian |
6.231600E-02 |
| Caucasian-vs-AfricanAmerican |
1.358800E-01 |
| Caucasian-vs-Asian |
5.423000E-01 |
| AfricanAmerican-vs-Asian |
8.301500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.018500E-02 |
| Normal-vs-Female |
1.810220E-01 |
| Male-vs-Female |
2.573600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.770800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.066300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.233800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.287840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.986190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.602200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.050800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.653200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.638200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.646400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.256000E-01 |
| Classical-VS-Follicular |
2.239800E-03 |
| Classical-VS-Other |
7.815800E-02 |
| Classical-VS-Normal |
5.104400E-01 |
| Tall-VS-Follicular |
2.778200E-01 |
| Tall-VS-Other |
1.779190E-01 |
| Tall-VS-Normal |
2.207200E-01 |
| Follicular-VS-Other |
4.716600E-01 |
| Follicular-VS-Normal |
5.818700E-03 |
| Other-VS-Normal |
2.888400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.662000E-02 |
| Normal-vs-N1 |
7.790100E-02 |
| N0-vs-N1 |
7.750400E-01 |
|
|
